Takashi Kobayashi

Induction of Hyper Th1 Cell-Type Immune Responses by Dendritic Cells Lacking the Suppressor of Cytokine Signaling-1 Gene

Toshikatsu Hanada, Kentaro Tanaka, Yumiko Matsumura et al. · The Journal of Immunology · 2005 · 96 citations · Full text

A phase II trial of erlotinib in patients with EGFR wild-type advanced non-small-cell lung cancer

Takashi Kobayashi, Tomonobu Koizumi, Toshihide Agatsuma et al. · Cancer Chemotherapy and Pharmacology · 2012 · 45 citations

Phase Ii Trial, Non-small-cell Lung Cancer, Medicine +7

Safety and tolerability of allogeneic dendritic cell vaccination with induction of Wilms tumor 1–specific T cells in a pediatric donor and pediatric patient with relapsed leukemia: a case report and review of the literature

Shoji Saito, Ryu Yanagisawa, Kentaro Yoshikawa et al. · Cytotherapy · 2014 · 42 citations

Vaccination, Tumor Immunology, Cancer Immunosurveillance +13

Prostaglandin E2 is a major soluble factor produced by stromal cells for preventing inflammatory cytokine production from dendritic cells

Hiroshi Shiraishi, Hiroki Yoshida, Koichi Saeki et al. · International Immunology · 2008 · 40 citations · Full text

Dendritic Cell-Based Adjuvant Vaccination Targeting Wilms’ Tumor 1 in Patients with Advanced Colorectal Cancer

Shigetaka Shimodaira, Kenji Sano, Koichi Hirabayashi et al. · Vaccines · 2015 · 38 citations · Full text

Immunology, Immune Regulation, Immunodominance +24